Business Combination - Narrative (Details) $ / shares in Units, $ in Thousands			3 Months Ended
	May 07, 2026 shares	Dec. 04, 2025 USD ($) shares $ / shares	Mar. 31, 2026 USD ($) $ / shares	Mar. 31, 2025 USD ($)	Dec. 31, 2025 USD ($) $ / shares
Business Combination, Separately Recognized Transaction [Line Items]
Common stock, par value (in dollars per share) | $ / shares			$ 0.0001		$ 0.0001
Fair value of contingent consideration			$ 125,554		$ 118,360
Contingent consideration payable, current portion			22,350		21,580
Contingent consideration payable, long-term portion			103,204		96,780
Revaluation of contingent consideration			6,120	$ 0
Foresight Diagnostics, Inc.
Business Combination, Separately Recognized Transaction [Line Items]
Total Foresight Diagnostics consideration		$ 424,536
Issuance of common stock pursuant to asset acquisition, net (in shares) | shares		1,127,982
Common stock, par value (in dollars per share) | $ / shares		$ 0.0001
Share price (in dollars per shares) | $ / shares		$ 242.06
Shares conversion ratio (in shares) | shares		0.0280
Fair value of contingent consideration		$ 118,360	125,600		118,400
Foresight Diagnostics’ indebtedness settled by the Company		5,974
Foresight Diagnostics’ transaction expenses settled by the Company		7,232
Potential future milestone obligations		175,000
Contingent consideration payable, current portion		21,600	22,400
Contingent consideration payable, long-term portion		$ 96,800			$ 103,200
Revaluation of contingent consideration			7,200
Number of shares deposited in escrow (in shares) | shares		9,505
Estimated fair value of the adjustment escrow shares		$ 2,300
Stockholder representative allocable expenses		1,000
Acquisition related costs		3,900
Acquisition related costs recorded		$ 100
Goodwill, measurement period adjustment			200
Adjustment, consideration transferred			$ 200
Foresight Diagnostics, Inc. | Subsequent Event
Business Combination, Separately Recognized Transaction [Line Items]
Shares deposited in escrow account for purchase price adjustments, returned (in shares) | shares	1,087
Foresight Diagnostics, Inc. | Developed Technology
Business Combination, Separately Recognized Transaction [Line Items]
Discount rate used		12.00%